Duality Advisers’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-17,301
Closed -$714K 909
2022
Q1
$714K Sell
17,301
-10,053
-37% -$354K 0.08% 408
2021
Q4
$1.17M Buy
+27,354
New +$1.37M 0.13% 264
2021
Q3
Sell
-33,929
Closed -$1.62M 735
2021
Q2
$1.62M Buy
33,929
+24,685
+267% +$1.26M 0.14% 241
2021
Q1
$468K Buy
+9,244
New +$514K 0.04% 454

Other funds holding SILK

Duality Advisers's SILK Position: Q2 2022 in Review

Duality Advisers sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2022, closing a stake of 17,301 shares — an estimated $714K sold.

Duality Advisers first reported a position in SILK in Q1 2021 and held it in 4 quarters. The position peaked at $1.62M in Q2 2021. 139 funds tracked by Wall St. Rank hold SILK as of Q2 2022.

  • Duality Advisers reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Duality Advisers sold 17,301 Silk Road Medical, Inc. Common Stock shares in Q2 2022, an estimated $714K.
  • Duality Advisers first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Duality Advisers's Silk Road Medical, Inc. Common Stock position peaked at $1.62M in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2022.

Based on Duality Advisers's 13F filing for Q2 2022, filed 8 Aug 2022.